baber/WOPTO huggingface dataset:
Patent NZ-200125-A (NZ)
Title: Gonadotropin antagonistic peptide derivatives
Inventor: RIVIER J E F
IPC: C07K7/06
Filed: 1982-03-24
Abstract: Peptides which inhibit the secretion of gonadotropins by the pituitary gland and inhibit the release of steroids by the gonads. Administration of an effective amount prevents ovulation of female mammalian eggs and/or the release of steroids by the gonads. The peptides have the structure.  X-R1-R2-R3-Ser-Tyr-R4-R5-Arg-Pro-R6 wherein X is hydrogen or an acyl group having 7 or less carbon atoms; R1 is dehydro Pro or dehydro D-Pro; R2 is D-Phe, Cl-D-Phe, dichloro-D-Phe, CF3-D-Phe, F-D-Phe, difluoro-D-Phe, AcNH-D-Phe, NO2-D-Phe, dinitro-D-Phe, Br-D-Phe, dibromo-D-Phe, CH3-S-D-Phe, OCH3-D-Phe or CH3-D-Phe; R3 is D-Trp or B-D-NAL; R4 is a D-isomer amino acid and preferably B-D-NAL; R5 is Leu or N< alpha >Me-Leu; and R6 is Gly-NH2 or NHCH2CH3; provided however that either R3 or R4 is B-D-NAL.
Patent NZ-204666-A (NZ)
Title: Olefin polymerisation catalyst supports containing magnesium chloride
Inventor: BAILLY J C
IPC: C08F10/00
Filed: 1983-06-21
Abstract: The present invention relates to catalyst supports for the polymerization and co-polymerization of alpha-olefins, especially ethylene and propylene, consisting essentially of magnesium chloride, characterized in that these supports occur in the form of spheroidal particles with a mean particle size by mass comprised between 10 and 100 microns and having a narrow particle size distribution, which can be controlled, such that the ratio of the mean diameter by mass to the mean diameter by number of the particles is less than or equal to 3.0, and the process for the preparation of the said supports.
Patent NZ-215781-A (NZ)
Title: Di-benz(b,e)oxepinacetic acid derivatives and preparation
Inventor: PURCELL T
IPC: C07D313/12
Filed: 1986-04-10
Abstract: Compounds of general formula   <IMAGE>   in which R1, taken separately, denotes a hydrogen atom or a C1-C4 alkyl group, and R2, taken separately, denotes a hydrogen atom, a C1-C4 alkyl group or a phenylthio or phenylsulphonyl group, or alternatively R1 and R2 together form an ethano bridge or, together with the two carbon atoms 8 and 9, form a fused benzene ring, R3 denotes a hydrogen atom or a methyl group and R4 denotes a hydrogen atom, a C1-C4 alkyl group or a cation of a base which is acceptable in pharmacology, the group CH(R3)COOR4 being at position 2 or 3. have uses in treatment of inflammation, pain and undesirable platelet aggregation.
Patent NZ-221197-A (NZ)
Title: Bicyclo(4,2,0)octane derivatives and pharmaceutical compositions
Inventor: KLUGE A F
IPC: C07C35/31
Filed: 1987-07-27
Abstract: Compounds useful in treating cardiovascular disorders such as thrombosis, hypertension, and atherosclerosis and in inhibiting gastric acid secretion are compounds depicted in formulas (1), (2), and (3): <CHEM>  wherein:  Y is exo-(lower alkyl) or endo-(lower alkyl);  n is 2 or 3;  R1 is CH2OH, CHO, CO2R or CO2H;  R2 is hydrogen or methyl; and  R3 is linear or branched alkyl having 5-10 carbon atoms, <CHEM> optionally substituted with lower alkyl, lower alkoxy, trifluoromethyl, or halogen,  in which  a is 0, 1 or 2;  b is 3-7;  m is 1 or 2; and  R is <CHEM>  wherein X is <CHEM> in which each R4 is independently hydrogen or lower alkyl having 1-6 carbon atoms, and the pharmaceutically acceptable, non-toxic salts and esters thereof.
Patent NZ-234656-A (NZ)
Title: Spout for piercing of and securement to a plastic pouch with force of piercing substantially constant
Inventor: HARRISON RAYMOND PETER
IPC: B67B7/86
Filed: 1990-07-26
Abstract: A spout is disclosed, for insertion into and securement to a plastic pouch. The spout comprises a tube (11) having a piercing portion (13) separated from a delivery portion (12) by a film securement portion (22) and having fluid flow communication from the piercing portion to the delivery portion. The film securement portion (22) is adapted to secure, with a substantially liquid-tight seal, plastic film which has been pierced by the piercing portion. The piercing portion (13) appears, in one perspective, to have been sliced at an angle to the longitudinal axis from a first location (23) at one side of said tube adjacent the film securement portion to a second location (14) at the other side of the tube, distal from the film securement portion, to form a tip (14) and to provide a slot (25) which aims to aid in draining material from the pouch, and the tip appears, in a second perspective perpendicular to the first perspective, to have been sliced symmetrically about the longitudinal axis of the tube to form a pointed piercing tip furthest away from the film securement portion (22). The contours of these slices are such that when the pointed tip (14) is pushed into the film, the force required remains substantially constant.
Patent NZ-238612-A (NZ)
Title: Coated veterinary implant comprising a solid core of biologically active material in a release inhibiting coating of polyvinyl alcohol
Inventor: CASTILLO ERNESTO JESUS
IPC: A61K9/22
Filed: 1991-06-19
Abstract: Solid dosage forms of bioactive materials for parenteral administration such as porcine or bovine somatotropin pellets intended for subcutaneous implantation to improve food production of farm animals are coated with polyvinyl alcohol to extend the release characteristics of the material. The polyvinyl alcohol preferably has a molecular weight of from about 20,000 to 100,000, a degree of hydrolysis of at least about 98%, and is applied from an aqueous solution by spray coating to form a continuous uniform covering of from about 3 to 25 ug/mm<2> PVA/surface area of pellet.
Patent NZ-250330-A (NZ)
Title: 15-deoxy-spergualin analogs, medicaments and preparation
Inventor: RENAUT PATRICE
IPC: C07C279/12
Filed: 1993-11-30
Abstract: The present invention relates to compounds of structure related to that of 15-deoxyspergualine, as new industrial products. These new compounds correspond to the formula: <IMAGE>  in which:     - n is equal to 6 or 8, - A represents a single bond, CH2, CHF, CH(OH), CH(OCH3), CH2NH or CH2O,  and their addition salts. These new compounds are useful as immunosuppressants.
Patent NZ-253976-A (NZ)
Title: Aerator for liquids: sidestream from reactor passed through slot-shaped venturi.
Inventor: BATTERHAM ROBIN JOHN
IPC: B01J8/18
Filed: 1993-07-09
Abstract: PCT No. PCT/AU93/00340 Sec. 371 Date Mar. 16, 1994 Sec. 102(e) Date Mar. 16, 1994 PCT Filed Jul. 9, 1993 PCT Pub. No. WO94/01210 PCT Pub. Date Jan. 20, 1994.A reactor for introducing gas into a fluid comprises a mixing tank (12, 43) for the fluid and a partition means (13,45) for dividing the tank into at least two chambers (21, 89) and (23, 91). The reactor further comprises a first pump means (14, 47) located in one of the chambers for circulating the fluid downwards in one chamber and then upward in the other chamber and an aerator assembly (29, 49) for aerating a sidestream of the fluid and introducing the aerated fluid into the tank for mixing the aerated fluid with the circulating fluid in the tank. The aerator assembly comprises a bank of venturi aerators (38, 57) each having an aerator inlet; an aerator outlet; and a constriction intermediate the aerator inlet and the aerator outlet for creating a region of reduced pressure in the fluid, the constriction being elongate in a section transverse to the direction of flow of the fluid through the constriction; and a means for introducing the gas into the constriction to aerate the fluid.
Patent NZ-262088-A (NZ)
Title: Gravity fed fluid treatment system using irradiation: fluid confined to predefined maximum distance from radiation source
Inventor: MAARSCHALKERWEERD JAN M
IPC: C02F1/32
Filed: 1994-03-04
Abstract: The invention relates to a cleaning apparatus for a radiation source assembly in a fluid treatment system. The invention is characterized in that the cleaning apparatus comprises:   a cleaning sleeve engaging a portion of the exterior of a radiation source in the radiation source assembly and movable between: (i) a retracted position wherein a portion of the radiation source is exposed to a flow of fluid to be treated, and (ii) an extended position wherein the portion of the radiation source is completely or partially covered by the cleaning sleeve, the cleaning sleeve further comprising a chamber in contact with the portion of the radiation source, the chamber adapted for receiving a cleaning fluid suitable to remove undesired materials from the portion of the radiation source upon movement of the cleaning sleeve.     <IMAGE>
Patent NZ-262449-A (NZ)
Title: Process for manufacture of aminomethanephosphonic acid and its use to prepare glyphosate
Inventor: RANDLES KENNETH RICHARD
IPC: C07F9/40
Filed: 1994-03-15
Abstract: A process for the manufacture of aminomethanephosphonic acid comprises: a) reacting a compound of formula R-CH2-NH-CO-NH-CH2-R' wherein R and R', which may be the same or different, represent a phosphonation leaving group with a phosphonating agent and subsequently b) hydrolysing the product of step (a) to form aminomethanephosphonic acid.
Patent NZ-263348-A (NZ)
Title: Nucleic acid coding sequence for tumour rejection antigen presented by human leukocyte antigen a2 molecules, vectors, host cells and treatment and diagnosis involving the antigen
Inventor: BRICHARD VINCENT
IPC: G01N33/574
Filed: 1994-03-09
Abstract: The invention relates to nucleic acid molecules coding for a tumor rejection antigen precursor. Specifically, the tumor rejection antigen precursor, or "TRAP", is processed into at least one tumor rejection antigen, which is presented by HLA-A2 molecules. Ramifications of the discovery are also set forth.
Patent NZ-269849-A (NZ)
Title: Urea derivatives; phenoxyphenyl cyclopentenyl hydroxyureas and pharmaceutical compositions containing them
Inventor: KAWAI AKIYOSHI
IPC: C07C275/64
Filed: 1994-08-15
Abstract: PCT No. PCT/JP94/01349 Sec. 371 Date May 24, 1996 Sec. 102(e) Date May 24, 1996 PCT Filed Aug. 15, 1994 PCT Pub. No. WO95/05360 PCT Pub. Date Feb. 23, 1995The invention relates to compounds of the formula   <IMAGE>   and to pharmaceutically acceptable salts thereof, wherein R1 is hydrogen, fluoro, or chloro, and R2 is hydrogen or methyl. The above compounds are lipoxygenase inhibitors. The invention also relates to pharmaceutical compositions containing the above compounds, and to methods of treating inflammatory and allergic conditions by administering the above compounds.
Patent NZ-272306-A (NZ)
Title: Process for preparing guar gum (or other polygalactomannans) and compositions thereof
Inventor: YEH MICHAEL H
IPC: C08B37/00
Filed: 1995-06-08
Abstract: Guar gum which demonstrates greater than 75% light transmission at a wavelength of from about 500-600 nanometers when dispersed in water in the amount of 0.5 parts per 100 parts water and the process for producing such guar gum is disclosed.
Patent NZ-287378-A (NZ)
Title: Soft closing pilot operated liquid valve with restricted flow path through diaphragm, and diaphragm assembly
Inventor: LUPPINO COSMO
IPC: F16K31/40
Filed: 1995-05-31
Abstract: PCT No. PCT/AU95/00325 Sec. 371 Date Nov. 26, 1996 Sec. 102(e) Date Nov. 26, 1996 PCT Filed May 31, 1995 PCT Pub. No. WO95/33155 PCT Pub. Date Dec. 7, 1995A soft closing liquid valve of the pilot control type including an inlet chamber, an outlet chamber, a third pilot chamber, a first conduit for liquid communication between the inlet chamber and the third chamber and a second conduit for fluid communication between the third chamber and the outlet chamber whereby the liquid flow rate through the first conduit is reduced by the conduit including a tortuous path means so that the flow rate into the third chamber is substantially reduced and when the second conduit is closed causes the third chamber to fill at a slower rate than in conventional pilot controlled valves, the resultant slow rate of change of pressure causing a slow closure of the flow path between the inlet and outlet chambers by a diaphragm thus minimizing water hammer. The first conduit may include a third conduit and a fourth chamber in liquid communication with the tortuous path, the third conduit acting as a filter means for the tortuous path by selecting its cross-sectional size to be smaller than that of the tortuous path. In another embodiment, the first conduit is formed through and using the peripheral bead of the diaphragm.
Patent NZ-291779-A (NZ)
Title: Golf buggy follows golfer at a predetermined distance using gps to calculate positions of buggy and golfer
Inventor: BAIL GUNTHER
IPC: A63B55/60
Filed: 1995-09-06
Abstract: PCT No. PCT/DE95/01211 Sec. 371 Date Mar. 19, 1997 Sec. 102(e) Date Mar. 19, 1997 PCT Filed Sep. 6, 1995 PCT Pub. No. WO96/09575 PCT Pub. Date Mar. 28, 1996A golf cart or caddy and a mobile transmitting device carried by a golf player are each provided with a receiving and evaluating device equipped with a computer for a satellite-controlled positioning system. The two receiving and evaluating devices calculate the respective positions of the golf player and the golf caddy from the signals cyclically received from the satellite system. The mobile transmitting device is provided with a high-frequency manual transmitter which transmits, also cyclically, the positions of the golf player to the golf caddy. The computer of the golf caddy calculates direction and distance of the golf player and stores the data up to the time when the caddy follows the stored path upon a signal. The golf caddy stops at a predetermined distance from the golf player. When a stationary reference transmitter is additionally used for correcting the position data of the golf player and the golf caddy received from the satellite system, specific areas of the golf course can be excluded as forbidden areas, so that these will not be traveled by the golf caddy.
Patent NZ-292595-A (NZ)
Title: Ruminant feedstuff additive comprising a choline salt
Inventor: CHANDLER PETER JOHN
IPC: A23K1/16
Filed: 1995-09-15
Abstract: Feedstuffs for domesticated animals can be improved by inclusion of choline e.g. as choline chloride. Ruminants cannot benefit from choline in feed unless the choline is protected from destruction in the rumen. Improved protection against ruminal destruction is provided by supporting the choline compound, especially as an aqueous solution, on a carrier particularly ground corn cob, other similar cellulosic material, or porous hydrophilic silica, and coated with or included within a matrix of a protective fatty acid or soap having a melting point above 40  DEG C. Even better results can be obtained by including alkali with the choline compound to form caps of soap over the choline compound in the pores of the carrier and/or to plasticise the fatty acid matrix.
Patent NZ-299034-A (NZ)
Title: Using lanthionine-containing bacteriocin to prevent or treat gastrointestinal disorders caused by pathogenic microorganisms
Inventor: BLACKBURN PETER
IPC: A61K35/74
Filed: 1993-01-15
Abstract: The specification describes the use of lanthionine-containing bacteriocin to treat GI disorders.  The bacteriocin is selected from nisin, subtilin, epidermin, Pep 5, ancovenin, gallidermin, duromycin and cinnamycin
Patent NZ-299984-A (NZ)
Title: 3-hydroxy-4-imidazolidinone; preparation and medicament
Inventor: CORDI ALEX
IPC: A61P25/28
Filed: 1996-12-20
Abstract: 3-Hydroxy-4-imidazolidinone of formula (I) and its salts are new.   (I) is prepared by reacting glycine hydroxamic acid of formula (II) H2N-CH2-CO-NH-OH with an aqueous formaldehyde solution.
Patent NZ-333222-A (NZ)
Title: Progressive cavity pump
Inventor: MARZ HORST FRITZ
IPC: F04C14/28
Filed: 1997-06-09
Abstract: A rotor assembly for a progressive cavity (pc) pump comprises a rotor member 10 including a cavity 12 and a rotor shaft 13 extending at least partially in cavity 12.  Rotor shaft 13 is joined to rotor member 10 by means of a connecting member featuring a thermally-induced structural failure capability that provides a tamper-proof fail-safe mechanism against overheating.  In a preferred embodiment the connecting member is made of low temperature melting alloy that converts into the liquid state at a temperature beyond which the operation of the pump may no longer be safe.  If the pump overheats, as a result of deadhead operation or dry pumping, the connecting member melts thus terminating the driving relationship between rotor shaft 13 and rotor member 10.  Rotor member 10 in a condition of mesh with the connecting member.  The rotor may be connected to a motor via a drive shaft that is isolated from the material flowing through the suction chamber of the pump, thereby preventing the pumped material from reaching the joints of the drive shaft through faulty seals.  The pc-pump is particularly useful for pumping explosives.
Patent NZ-333580-A (NZ)
Title: Non-Aqueous protic peptide formulations, preferably LHRH
Inventor: ECKENHOFF JAMES B
IPC: A61K38/00
Filed: 1997-07-01
Abstract: This specification describes stable non-aqueous protic formulations of peptide compounds. The non-aqueous protic solvent  is, preferably, DMSO or DMF and the peptide is a LHRH, leuprolide, nafarelin or goserelin.  The formulations may be stored at elevated temperatures for long periods of time and are especially useful in implantable delivery devices for long term delivery of drug.
Patent NZ-333713-A (NZ)
Title: Compounds for treating diseases associated with tryptase activity
Inventor: DENER JEFFREY MARK
IPC: C07D295/20
Filed: 1997-07-30
Abstract: Compounds of formula 1 wherein, X5 is cis-1,5-cyclooctylene and X4 and X6 each are a covalent bond or X5 is 1,4-phenylene and X4 and X6 are (C0-1)alkylene, X1 and X9 are independently a covalent bond, C(O), NHC(O), C(O)NH, N(CH3)C(O) or S(O)2NH, X3 and X7 are independently C(O) or C(O)O, X2 and X8 are independently -X10-X11-, wherein X10 is a covalent bond or methylene and X11 is 4,1-piperidylene or 1,4-piperazinylene, R1 is -R4-X12- or -R5-X13-, wherein R4 is amidino, guanidino or methylamino, X12 is -X14-X15-X16-, wherein X15 is 1,4-phenylene or 1 ,4-piperidylene, X14 is (Cn14)alkylene and X16 is (Cn16)alkylene, wherein the sum of n14 and n16 is 0, 1 or 2, R5 is piperid-4-yl and X13 is (C2-3)alkylene and R2 is R8-X20 or R9-X21, wherein R8 is amino, methylamino or 1-iminoethyl, X20 is -X22-X23-X24-, wherein X23 is trans-1,4-cyclohexylene, 1,4-phenylene, 4,1-pyridylene, 1,4-piperidylene, X22 is (Cn22)alkylene and X24 is C(n24)alkylene, wherein the sum of n22 and n24 is 1 or 2, R9 is benzoimidazol-5-yl, imidazol-1-yl, imidazol-4-yl, 2-imidazolin-2-yl, 4-methylimidazol-1-yl, 5-methylimidazol-1-yl, 1-methylpiperid-4-yl, piperid-4-yl, piperazin-1-yl, pyrid-3-yl, 1,4,5,6-tetrahydropyrimidin-5-yl or 1,4,5,6-tetrahydro-2-dioxopyrimidin-5-yl and X21 is (C1-6)alkylene, omega-aza(C2-5)alkylene, 2-aza-3-oxotrimethylene, 3-aza-2-oxotrimethxylene, 3-oxotrimethylene, omega-thia(C2-4)alkylene or -X25-X26-X27-, wherein X26 is 1,4-phenylene, X25 is (Cn25)alkylene and X27 is (Cn27)alkylene, wherein the sum of n25 and n27 is 0 or 1 and the pharmaceutically acceptable salts, N-oxides, prodrug derivatives and protected derivatives thereof. These compounds are useful in the treatment of diseases where tryptase activity contributes to the pathology and/or symptomatology of the disease.
Patent NZ-338093-A (NZ)
Title: Methods and materials for making and using transgenic dicamba-degrading organisms
Inventor: WEEKS DONALD P
IPC: C12N15/82
Filed: 1998-04-03
Abstract: The dicamba-degrading O-demethylase is a combination of a dicamba-degrading ferredoxin, a dicamba-degrading oxygenase and a dicamba-degrading reductase.  Provided are the isolated and at least partially-purified dicamba-degrading enzymes, isolated DNA molecules and DNA constructs coding for the enzymes, and transgenic host cells and plants comprising DNA coding for dicamba-degrading enzymes. Expression of the dicamba-degrading enzymes results in the production of dicamba-degrading organisms, including dicamba-tolerant plants. Applying dicamba can control weeds in a field containing the transgenic dicamba-tolerant plants.  A material containing dicamba may be decontamined by applying an effective amount of a transgenic microorganism or dicamba-degrading enzyme to the material. The transformed plants and plant cells may be selected based on dicamba tolerance.  The transformed host cells, intact organisms and parts of organisms may be screened on the basis of the fluorescence of 3,6-dichlorosalicylic acid produced as a result of dicamba degradation.
Patent NZ-505115-A (NZ)
Title: Nucleus and method for producing half or mabe pearls
Inventor: LANGDON RICHARD WILLIAM NEWNMA
IPC: A01K61/00
Filed: 1998-11-17
Abstract: A nucleus for the production of half or mabe pearls in molluscs. The nucleus comprises a first portion having an external surface adapted to define the shape of the half or mabe pearl to be produced and a second portion which defines a bridge between said first portion and the shell of the host mollusc. The half or mabe pearls so produced have a substantially even cross section of nacre formed over the nucleus, and a generally reduced time is required for the formation of the pearl.
Patent NZ-509932-A (NZ)
Title: Interlock mechanism with spring forced to open position by actuator having ramped engaging surfaces
Inventor: DRIESSEN LEO
IPC: B25F3/00
Filed: 2001-02-14
Abstract: Interlock mechanism for releasably coupling first and second portions of a power tool (10) comprising a spring normally biassed to a first, closed position and an actuator co-operable with the spring to urge the spring, under influence of the actuator, into a second, open position, and the interlock mechanism characterised by the actuator having a spring-engaging surface formed from a plurality of individual surfaces which are not coplanar.
Patent NZ-512454-A (NZ)
Title: Passenger tracking system, for example in airports, using radio signal transceivers located around the terminal
Inventor: LOWTHER JONATHAN RAE
IPC: G01S1/08
Filed: 2001-06-19
Abstract: A passenger location system includes radio transceivers located around the terminal facility, and each passenger to be located carries a radio transponder tag which in response to interrogation by a transceiver responds to several of the transceivers with the identity of the passenger carrying the responder which is stored in the memory of the responder. The location of the responder can be determined from the response signals received by the several transceivers.
Patent NZ-514039-A (NZ)
Title: Lubricant for magnetic recording medium and use thereof
Inventor: GUNSEL SELDA
IPC: C07C233/05
Filed: 2000-03-24
Abstract: Compositions selected from the group consisting of hydrocarbyl-substituted cyclopentanes, hydrocarbyl-substituted cyclopentenes, and hydocarbyl-substituted cyclopentadienes are described. The compositions may be used in a lubricant layer on a magnetic head for reading and writing on a magnetic recording medium. Also described is a magnetic head comprising a head and a lubricant layer over at least a portion of the head, the lubricant layer comprising a composition according to the invention. The magnetic recording medium and the magnetic head may be used to manufacture computer disk drives, compact disk drives, audio equipment, and video equipment.
Patent NZ-518669-A (NZ)
Title: Therapeutic or prophylactic vaccination against cancer using antibodies recovered from serum by immunoaffinity purification
Inventor: LOIBNER HANS
IPC: C12N5/07
Filed: 2000-11-15
Abstract: Described is the use of antibodies, which bind to antibodies for tumour-associated antigens and which are obtained from individual body fluids by immuno-affinity purification with specific ligands, for the production of individual, autologous, prophylactic or therapeutic vaccination against cancerous disease states.  The ligands for immuno-affinity purification are antibodies or derivatives thereof, to tumour associated antigens.  Pharmaceutical compositions, which comprise the antibodies produced by immuno-affinity purification, or the dendritic cells pulsed in vitro by the aforementioned antibodies are described also.